author-photo

Carla Codecà

University of Milan

36

Papers

526

Citations

Citation Trend

Filter By

Papers (21) Sort By

Journal Conference Others

Correction to: Immunohistochemical evaluation of microsatellite instability in resected colorectal liver metastases: a preliminary experience

2020 Medical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
399O Oxaliplatin plus fluoropyrimidines as adjuvant therapy for colon cancer in elderly patients: A subgroup analysis from TOSCA trial

2020 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (2)
Cancer patients in COVID-19 outbreak: something more than Suram fortress.

2020 Medical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
The Slippery Role of Induction Chemotherapy in Head and Neck Cancer: Myth and Reality

2020 Frontiers in Oncology
Show All
- Source
- Cite
- Save
Citations (12)
Clinical outcomes and prognostic factors in recurrent and/or metastatic head and neck cancer patients treated with chemotherapy plus cetuximab as first-line therapy in a real-world setting

2019 European Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (11)
Long-term disease-free survival in surgically-resected oral tongue cancer: a 10-year retrospective study

2019 Acta Otorhinolaryngologica Italica
Show All
- Source
- Cite
- Save
Citations (9)
Disseminated cytomegalovirus disease after bendamustine: a case report and analysis of circulating B- and T-cell subsets

2019 BMC Infectious Diseases
Show All
- Source
- Cite
- Save
Citations (7)
Chemotherapy and immunotherapy for recurrent and metastatic head and neck cancer: a systematic review

2018 Medical Oncology
Show All
- Source
- Cite
- Save
Citations (28)
1094PClinical prognostic factors in patients (pts) with recurrent and/or metastatic (RM) head and neck carcinoma (HNC) treated with cetuximab plus chemotherapy

2018 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Induction TPF followed by concomitant treatment versus concomitant treatment alone in locally advanced head and neck cancer. A phase II–III trial

2017 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (94)